Highline Wealth Partners’s Monster Beverage MNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.6K Buy
326
+10
+3% +$463 ﹤0.01% 570
2026
Q2
$15.2K Buy
316
+28
+10% +$1.18K ﹤0.01% 451
2026
Q1
$10.4K Sell
288
-30
-9% -$1.18K ﹤0.01% 436
2025
Q4
$12.2K Buy
318
+32
+11% +$1.15K ﹤0.01% 357
2025
Q3
$9.6K Buy
286
+128
+81% +$4K ﹤0.01% 421
2025
Q2
$4.95K Buy
158
+66
+72% +$2.02K ﹤0.01% 447
2025
Q1
$2.69K Buy
92
+18
+24% +$469 ﹤0.01% 575
2024
Q4
$1.94K Buy
74
+38
+106% +$1.01K ﹤0.01% 461
2024
Q3
$939 Hold
36
– – ﹤0.01% 511
2024
Q2
$899 Hold
36
– – ﹤0.01% 459
2024
Q1
$1.07K Hold
36
– – ﹤0.01% 370
2023
Q4
$1.04K Hold
36
– – ﹤0.01% 340
2023
Q3
$953 Hold
36
– – ﹤0.01% 315
2023
Q2
$1.03K Hold
36
– – ﹤0.01% 268
2023
Q1
$972 Buy
36
+8
+29% +$205 ﹤0.01% 269
2022
Q4
$711 Buy
+28
New +$678 ﹤0.01% 281

Other funds holding MNST

Highline Wealth Partners's MNST Position: Q3 2026 in Review

Highline Wealth Partners increased its Monster Beverage (MNST) stake by 3.2% in Q3 2026, buying an estimated $463 and bringing the position to 326 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Highline Wealth Partners first reported a position in MNST in Q4 2022 and has held it in 16 quarters since. The position peaked at $15.2K in Q2 2026. 1,127 funds tracked by Wall St. Rank hold MNST as of Q3 2026.

  • Highline Wealth Partners held 326 shares of Monster Beverage worth $13.6K as of Q3 2026.
  • Highline Wealth Partners bought 10 Monster Beverage shares in Q3 2026, an estimated $463.
  • Monster Beverage made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #570 holding.
  • Highline Wealth Partners first reported a position in Monster Beverage in Q4 2022 and has held it in 16 quarters since.
  • Highline Wealth Partners's Monster Beverage position peaked at $15.2K in Q2 2026.
  • 1,127 funds tracked by Wall St. Rank held Monster Beverage as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.